HBsAg LEVELS AT THE END OF LONG-TERM THERAPY (EOT) WITH NUCLEOS(T)IDE ANALOGUES (NA) AFFECT THE OUTCOMES OF NON-CIRRHOTIC PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B (CHBE-)Margarita Papatheodoridi,Emilia Hadziyannis,Afroditi Orfanidou,Kalliopi Zachou,Anastasia Kourikou, Anastasia Tzakou,Spilios Manolakopoulos,George N. Dalekos,Stephanos J. Hadziyannis,George V. PapatheodoridisHEPATOLOGY（2019）引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
